Biotie Therapies CorpShs News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

30.09.16	ACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST (GlobeNewswire)
26.09.16	ARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRADING HAS BEEN TERMINATED (GlobeNewswire)
26.08.16	Biotie: BTT1023 receives Orphan Drug Designation in the United States (GlobeNewswire)
25.08.16	THE LISTING COMMITTEE OF NASDAQ HELSINKI HAS RESOLVED TO DELIST THE SHARES OF BIOTIE THERAPIES CORP. (GlobeNewswire)
18.08.16	BIOTIE THERAPIES CORP. APPLIES FOR DELISTING OF ITS SHARES FROM NASDAQ HELSINKI (GlobeNewswire)
19.07.16	ARBITRATORS APPOINTED FOR THE REDEMPTION PROCEEDINGS OF BIOTIE'S MINORITY SHARES (GlobeNewswire)
29.06.16	CHANGES IN THE MANAGEMENT TEAM (GlobeNewswire)
21.06.16	Change in Biotie Therapies' Financial Reporting Calendar 2016 (GlobeNewswire)
13.06.16	BIOTIE ANNOUNCES THAT THE DELISTING OF ITS ADS HAS BECOME EFFECTIVE (GlobeNewswire)
10.06.16	TRUSTEE APPOINTED FOR THE REDEMPTION PROCEEDINGS CONCERNING BIOTIE'S MINORITY SHARES (GlobeNewswire)
18.05.16	NORDEA BANK FINLAND PLC'S MARKET-MAKING FOR BIOTIE THERAPIES CORP.'S SHARE ENDS (GlobeNewswire)
18.05.16	BIOTIE TO DELIST ITS ADS FROM THE NASDAQ GLOBAL SELECT MARKET (GlobeNewswire)
18.05.16	BIOTIE CANCELS ALL TREASURY SHARES HELD BY THE COMPANY (GlobeNewswire)
12.05.16	Biotie Interim Report 1 January - 31 March 2016 (GlobeNewswire)
03.05.16	RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. AND ORGANIZATION OF THE BOARD (GlobeNewswire)
02.05.16	FINAL RESULTS OF THE SUBSEQUENT OFFER PERIOD OF ACORDA'S TENDER OFFER FOR ALL SECURITIES IN BIOTIE (GlobeNewswire)
20.04.16	ACORDA THERAPEUTICS TO COMMENCE A COMPULSORY REDEMPTION PROCEEDING IN RESPECT OF THE REMAINING BIOTIE THERAPIES CORP. SHARES (GlobeNewswire)
20.04.16	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
14.04.16	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
13.04.16	FINAL RESULTS OF ACORDA'S TENDER OFFER AND COMMENCEMENT OF A SUBSEQUENT OFFER PERIOD (GlobeNewswire)
12.04.16	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
12.04.16	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
12.04.16	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
12.04.16	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
12.04.16	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
12.04.16	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
12.04.16	INVITATION TO THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. (GlobeNewswire)
11.04.16	ACORDA ANNOUNCES PRELIMINARY TENDER OFFER RESULTS AND ACCEPTANCE OF THE SECURITIES IN BIOTIE TENDERED IN TENDER OFFER (GlobeNewswire)
22.03.16	ACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER OFFER ON 22 MARCH 2016 (GlobeNewswire)
22.03.16	Biotie's Financial Statement Report and Corporate Governance Statement 2015 published (GlobeNewswire)
10.03.16	THE FINNISH FINANCIAL SUPERVISORY AUTHORITY HAS APPROVED THE TENDER OFFER DOCUMENT, ACORDA WILL COMMENCE THE VOLUNTARY PUBLIC TENDER OFFER ON 11 MARCH 2016 (GlobeNewswire)
04.03.16	STATEMENT OF THE BOARD OF DIRECTORS OF BIOTIE THERAPIES CORP. REGARDING THE VOLUNTARY PUBLIC TENDER OFFER BY ACORDA THERAPEUTICS, INC. (GlobeNewswire)
04.03.16	CHANGE IN THE TIME OF BIOTIE THERAPIES' ANNUAL GENERAL MEETING 2016 (GlobeNewswire)
03.03.16	ACORDA HAS FILED THE DRAFT TENDER OFFER DOCUMENT RELATING TO ITS PUBLIC TENDER OFFER FOR BIOTIE THERAPIES WITH THE FINNISH FINANCIAL SUPERVISORY AUTHORITY (GlobeNewswire)
19.02.16	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
17.02.16	U.S. antitrust regulation waiting period relating to tender offer has expired (GlobeNewswire)
12.02.16	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
19.01.16	CORRECTION ANNOUNCEMENT: ACORDA ANNOUNCES A RECOMMENDED CASH TENDER OFFER FOR ALL SHARES, ADSs AND OTHER EQUITY INSTRUMENTS IN BIOTIE (GlobeNewswire)
19.01.16	CORDA ANNOUNCES A RECOMMENDED CASH TENDER OFFER FOR ALL SHARES, ADSs AND OTHER EQUITY INSTRUMENTS IN BIOTIE (GlobeNewswire)
05.01.16	Biotie:Issuance of shares pursuant to option and equity incentive plans (GlobeNewswire)
05.01.16	The Board of Directors of Biotie Therapies Corp. has Approved Two Year Incentive Plan for Employees (GlobeNewswire)
22.12.15	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
14.12.15	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
14.12.15	Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
14.12.15	Biotie Therapies Oyj :Disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act (GlobeNewswire)
08.12.15	Biotie's financial information in 2016 (GlobeNewswire)
12.11.15	Biotie interim report 1 January - 30 September 2015 (GlobeNewswire)
10.11.15	Biotie to Present at the upcoming Stifel 2015 Healthcare Conference (GlobeNewswire)
21.07.15	Biotie announces start of tozadenant Phase 3 Study in Parkinson's disease (GlobeNewswire)
16.06.15	Biotie Announces Closing of U.S. Public Offering and Conversion of Convertible Notes (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’299.00	2.40 %	K V
Holcim	89.04	1.09 %	K V
Roche Hldg G	266.90	0.95 %	K V
ABB	49.88	0.81 %	K V
Novartis	90.96	0.63 %	K V
Givaudan	3’882.00	-0.54 %	K V
Zurich Insur Gr	547.20	-0.83 %	K V
Alcon	76.34	-1.14 %	K V
Logitech Intl	78.74	-1.43 %	K V
Geberit	505.80	-1.52 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Biotie Therapies CorpShs

Aktien Top/Flop

Meistgelesene Nachrichten